| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.7 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.7 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.7 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.7 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.7 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | 0.018 | 0.8 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |